Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Dendritic cell subsets in alopecia areata: focus on plasmacytoid dendritic cells and Langerhans cells in immune imbalance and therapeutic implications.

Expert review of clinical immunology·2026
Same author

Soluble CD83 reverses alopecia areata via IDO-mediated Treg cell activation.

The British journal of dermatology·2026
Same author

Dermatoscopic Features of Hyperpigmented Dermatoses.

Clinical, cosmetic and investigational dermatology·2026
Same author

Response to Zhang et al, "Mixing povidone-iodine and erythromycin ointment in skin wound management: a reconsidered practice".

Journal of the American Academy of Dermatology·2026
Same author

Bullous Tinea Corporis Due to <i>Microsporum canis</i>.

Journal of cutaneous medicine and surgery·2026
Same author

Oxidative Stress and Hormone-Regulated Dermal Papilla Cell-Targeted Nanomodulators: Reverse Cellular Senescence for Androgenetic Alopecia Therapy.

Biomaterials research·2026

Related Experiment Video

Updated: Jan 12, 2026

Murine Model of Epicutaneously-Induced Immunomodulation
09:07

Murine Model of Epicutaneously-Induced Immunomodulation

Published on: June 24, 2025

483

Sequential immunotherapy for alopecia areata: phase-driven immune rebalancing.

Yetan Shi1, Xiuzu Song2,3

  • 1The Fourth Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.

Expert Review of Clinical Immunology
|November 5, 2025
PubMed
Summary

Sequential immunotherapy offers a promising approach for treating alopecia areata (AA) by managing recurrence and treatment resistance. This strategy involves coordinated immunomodulatory interventions to restore hair follicle (HF) immune privilege and promote regrowth.

Keywords:
Alopecia areataautoimmunityimmunological mechanismregulation of immunitysequential immunotherapy

More Related Videos

A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis
06:41

A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis

Published on: March 9, 2015

9.4K
Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

14.9K

Related Experiment Videos

Last Updated: Jan 12, 2026

Murine Model of Epicutaneously-Induced Immunomodulation
09:07

Murine Model of Epicutaneously-Induced Immunomodulation

Published on: June 24, 2025

483
A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis
06:41

A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis

Published on: March 9, 2015

9.4K
Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

14.9K

Area of Science:

  • Immunodermatology
  • Trichology
  • Autoimmune diseases

Background:

  • Alopecia areata (AA) is an immune-mediated condition where T lymphocytes attack hair follicles (HFs).
  • AA significantly impacts patients' physical and mental well-being.
  • Current AA treatments face challenges with recurrence and resistance.

Purpose of the Study:

  • To review sequential immunotherapy strategies for alopecia areata.
  • To evaluate the potential of sequential immunotherapy for managing recurrent and treatment-resistant AA.
  • To explore how sequential immunotherapy restores HF immune privilege and homeostasis.

Main Methods:

  • Systematic review of articles from the PubMed database.
  • Evaluation of sequential immunotherapy strategies in conjunction with AA immune pathogenesis.
  • Analysis of efficacy and safety data for sequential immunotherapy.

Main Results:

  • Sequential immunotherapy combines intensive immunosuppression with maintenance therapy.
  • This approach addresses the dynamic nature of AA progression.
  • Potential for stage-specific modulation of inflammatory cascades and restoration of immune tolerance.

Conclusions:

  • Sequential immunotherapy presents a novel treatment model for alopecia areata.
  • It shows significant potential in managing recurrent and treatment-resistant cases.
  • Further research is needed to optimize efficacy and safety profiles.